BCL2 and neoplasm: miR-15a and miR-16 act as tumor suppressors: they downregulate multiple oncogenes (BCL2, MCL1, CCND1, and WNT3A), decreasing PC cell survival, proliferation, invasion, and EMT by targeting TGF-β signaling.